Skip Navigation

European Heart Journal 1989 10(Supplement F):119-126; doi:10.1093/eurheartj/10.suppl_F.119
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gansser, R. E.
Right arrow Articles by Bachmann, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gansser, R. E.
Right arrow Articles by Bachmann, K. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Dilatation of epicardial coronary arteries and attenuation of provoked coronary vasoconstriction by nisoldipine

R. E. Gansser and K. F. Bachmann

Universitaet Erlangen—Nuernberg 8520 Erlangen, F.R.G.

Address for reprints: Dr med. Rolf Gansser, Med. Klinik II und Poliklinik der Universitaet Erlangen—Nuernberg, Oestliche Stadtmauerstr. 29, 8520 Erlangen, F.R.G.

By using quantitative coronary angiography, this study evaluated the coronary artery dilative action of intravenous nisoldipine and furthermore examined the efficacy of the agent to prevent an ergonovine-provoked increase in the coronary arterial tone. Ten patients suspected of either vasospastic or mixed form of angina pectoris underwent coronary angiography under resting conditions, after 3 µg kg–1 of intravenous nisoldipine and finally after a cumulative dose of 0·7 mg of ergonovine maleate. The ergonovine-provocation was performed subsequent to a second intravenous administration of 3µg kg–1 nisoldipine. Coronary artery diameters were measured in angiographically normal, proximal segments by using a computer assisted procedure with automatic contour detection. The following results are given as the mean ± SEM of the percentage changes in the diameters of 30 coronary artery segments. Nisoldipine produced dilatation of the epicardial coronary arteries with a mean increase in the diameters by 9·5±1·3% with respect to baseline (P<001). Subsequent ergonovine-testing caused coronary artery vasoconstriction with a mean diameter decrease of 7·7±1·3% below baseline (P<0·01). Though nisoldipine did not totally block the ergonovine-induced increase in the coronary vasomotor tone, there was a significant attenuation of the coronary constriction compared with patients without any premedication (7·7±1·3% versus 13·6±0·6%, P<0·01). The ability of nisoldipine to dilate epicardial coronary arteries but also to reduce a provoked coronary artery constriction promises therapeutic effectiveness for both the prevention and release of angina pectoris caused by an increased coronary vasomotor tone.

Key Words: Nisoldipine • ergonovine • coronary vasomotor tone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.